Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Chronic kidney disease
•
Nephrology
What is your approach to managing constipation in patients with chronic kidney disease?
Related Questions
Do you check EPO levels in patients with anemia of chronic kidney disease?
What is your approach to weaning dialysis in a patient with AKI on CKD and CHF who now has resolved AKI but a history of recurrent episodes of decompensated heart failure?
Would you avoid SGLT2 inhibitors in patients with urinary incontinence requiring incontinence briefs due to concern with genitourinary hygiene and risk for infections?
What are some indications that might lead you to pursue a kidney biopsy in a patient with presumed diabetic kidney disease?
Do you avoid ESAs in patients with anemia and chronic kidney disease who also have Factor V Leiden?
Would you consider adding an SGLT2i for a patient with proteinuric kidney disease who is already on maximal dose ACEi/ARB and has a UACR < 300 mg/g?
How often do you screen for cerebral aneurysms in patients with autosomal dominant polycystic kidney disease who do not have a family history of intracranial aneurysms or for whom the family history is unknown?
How do you choose between spironolactone and finerenone for patients with proteinuric diabetic kidney disease and heart failure?
Do you prefer celecoxib over a nonselective NSAID in patients with chronic kidney disease?
Do you rule out active urinary tract infections prior to performing a kidney biopsy?
